Cora Hallas

Cora Hallas

Auto-generated profile, based on publicly available information

Cora Hallas

Hematopathology Hamburg, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2004 in Cell Death & Differentiation
Verified
Journal Article
Closed access
MHM Heinrich
M Heinrich
JNJ Neumeyer
J Neumeyer
MJM Jakob
M Jakob
CHC Hallas
C Hallas
VTV Tchikov
V Tchikov
SSS Schütze
S Schütze

23 February 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
KLKyeong‐Hee Lee
Kyeong‐Hee Lee
CFChristine Feig
Christine Feig
VTVladimir Tchikov
Vladimir Tchikov
RSRobert Schickel
Robert Schickel
CHCora Hallas
Cora Hallas
ACAndrew C Chan
Andrew C Chan
Activation of the cell surface CD95 receptor triggers a cascade of signaling events, including assembly of the death‐inducing signaling complex (DISC), that culminate in cellular apoptosis. In this study, we demonstrate a general requirement of receptor internalization for CD95 ligand‐mediated DISC amplification, caspase activation and apoptosis in type I cells. Recruitment of DISC components to the activated receptor predominantly occurs after the receptor has moved into an endosomal compartment and blockade of CD95 internalization impairs DISC formation and apoptosis. In contrast, CD95 ligand stimulation of cells unable to internalize CD95 results in activation of proliferative Erk and NF‐κB signaling pathways. Hence, the subcellular localization and internalization pathways of CD95 play important roles in controlling activation of distinct signaling cascades to determine divergent cellular fates.

27 March 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YPYuri Pekarsky
Yuri Pekarsky
CHCora Hallas
Cora Hallas
APAlexey Palamarchuk
Alexey Palamarchuk
AKAnatoliy Koval
Anatoliy Koval
FBFlorencia Bullrich
Florencia Bullrich
CCCarlo M. Croce
Carlo M. Croce
The immediate early gene NUR77 (also called NGFI-B ) is required for T cell antigen receptor-mediated cell death and is induced to very high levels in immature thymocytes and T cell hybridomas undergoing apoptosis. The Akt (PKB) kinase is a key player in transduction of anti-apoptotic and proliferative signals in T cells. Because Nur77 has a putative Akt phosphorylation site at Ser-350, and phosphorylation of this residue is critical for the transactivation activity of Nur77, we investigated whether Akt regulates Nur77. Coimmunoprecipitation experiments showed the detection of Nur77 in Akt immune complexes, suggesting that Nur77 and Akt physically interact. We further show that Akt specifically phosphorylates Ser-350 of the Nur77 protein within its DNA-binding domain in vitro and in vivo in 293 and NIH 3T3 cells. Because phosphorylation of Ser-350 of Nur77 is critical for its function as a transcription factor, we examined the effect of Akt on this function. By using luciferase assay experiments, we showed that phosphorylation of Nur77 by Akt decreased the transcriptional activity of Nur77 by 50–85%. Thus, we show that Akt interacts with Nur77 and inactivates Nur77 by phosphorylation at Ser-350 in a phosphatidylinositol 3-kinase-dependent manner, connecting the phosphatidylinositol 3-kinase-dependent Akt pathway and a nuclear receptor pathway.

29 November 2007 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
André FehrAndré Fehr
André Fehr
KRKerstin Röser
Kerstin Röser
KHKlaus Heidorn
Klaus Heidorn
CHCora Hallas
Cora Hallas
TLThomas Löning
Thomas Löning
Jörn BullerdiekJörn Bullerdiek
Jörn Bullerdiek

16 March 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YPYuri Pekarsky
Yuri Pekarsky
CHCora Hallas
Cora Hallas
MIMasaharu Isobe
Masaharu Isobe
GRGiandomenico Russo
Giandomenico Russo
CCCarlo M. Croce
Carlo M. Croce
The TCL1 oncogene on human chromosome 14q32.1 is involved in the development of T cell leukemia in humans. Its expression in these leukemias is activated by chromosomal translocations and inversions at 14q32.1. Here we report the isolation and characterization of a new member of the TCL1 gene family, TCL1b, located ≈16 kb centromeric of TCL1 . The 1.2-kb TCL1b cDNA encodes a 14-kDa protein of 128 aa and shows 60% similarity to Tcl1. Expression profiles of TCL1 and TCL1b genes are very similar: both genes are expressed at very low levels in normal bone marrow and peripheral lymphocytes but are activated in T cell leukemia by rearrangements of the 14q32.1 region. Thus, translocations and inversions at 14q32.1 in T cell malignancies involve two oncogenes.

10 September 2001 in Oncogene
Verified
Journal Article
Closed access
YPYuri Pekarsky
Yuri Pekarsky
CHCora Hallas
Cora Hallas
CCCarlo M Croce
Carlo M Croce